| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.09B | +32.3% | +9.7% |
| Cost of Revenue | $549.0M | +0.9% | +18.1% |
| R&D Expense | $587.0M | -3.8% | +12.0% |
| SG&A Expense | $330.0M | +7.5% | -1.5% |
| Operating Income | $1.63B | +165.5% | +6.6% |
| Pre-tax Income | $1.79B | +130.0% | +3.3% |
| Income Tax | $418.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.53B | +1.7% | -1.9% |
| Short-term Investments | $4.16B | +5.1% | +16.0% |
| Current Assets | $19.54B | -15.7% | +6.7% |
| Total Assets | $23.06B | -14.6% | +4.0% |
| Current Liabilities | $14.04B | -25.4% | +23.8% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.12B | — | — |
| Investing Cash Flow | -$448.0M | — | — |
| Financing Cash Flow | -$2.38B | — | — |
| +205.1% |
| +13.9% |
| Net Income | $1.37B | +114.0% | +0.4% |
| $0 |
| — |
| -100.0% |
| Total Liabilities | $14.45B | -24.8% | +5.6% |
| Stockholders' Equity | $8.61B | +10.6% | +1.4% |